PCa agent fails to extend survival in phase III trial.
In: Urology Times, Jg. 42 (2014-04-01), Heft 5, S. 15-15
serialPeriodical
Zugriff:
The article reports on an international phase III study of patients with metastatic castration-resistant prostate cancer (mCRPC) conducted by Dr. Robert Dreicer and colleagues which suggested that lyase inhibitor orteronel failed to significantly extend overall survival (OS).
Titel: |
PCa agent fails to extend survival in phase III trial.
|
---|---|
Autor/in / Beteiligte Person: | Kuznar, Wayne |
Zeitschrift: | Urology Times, Jg. 42 (2014-04-01), Heft 5, S. 15-15 |
Veröffentlichung: | 2014 |
Medientyp: | serialPeriodical |
ISSN: | 0093-9722 (print) |
Schlagwort: |
|
Sonstiges: |
|